UPS has announced a global expansion of its healthcare-specific capabilities to support clinical trials. UPS’s investments in a range of specialised solutions are expected to help pharmaceutical companies and clinical investigators move sensitive materials and specimens globally, particularly in and out of complex geographies.
Building on its integrated network, UPS has made advancements specifically targeted to meet strict clinical trial logistics requirements. Enhancements include: the healthcare compliant development of an easy-to-use shipping system for clinical investigator sites; an expansion of the healthcare control tower network, package intercept and re-icing capabilities; and upgraded operations to move temperature-sensitive biological specimens in and out of more than 60 countries more efficiently.
“As innovation in the biopharma industry evolves — and with the emergence of personalized therapies and growing direct-to-patient trends — research and development activity will only increase around the world. Our cost-effective portfolio streamlines logistics for clinical trials into one global network across sometimes remote, hard-to-reach locations,” said Habib N’Konou, UPS Senior Operations Director for clinical trials. “With drug research taking years at a cost in the billions, a product loss or damage, including falling out of temperature range, could mean a costly setback. Our recent improvements to our network can help reduce product loss or damage.”
UPS is aiming to mitigate risks by employing air freight and small package solutions for investigational medicinal products, specimen kits, ancillary supplies, and medical devices to and from investigator sites, contract research organizations, and diagnostic centres. UPS is providing customs brokerage as part of its clinical trials offering.
“Improved health outcomes through sophisticated drugs and vaccines starts with successful clinical trials,” said Geoff Light, UPS Vice President of Global Healthcare Strategy. “Optimized logistics is an integral component of medical research and development, and our goal is to help clinical investigators reach any part of the world with maximum efficiency. We will continue to invest in the right global solutions with the aim of becoming the preeminent leader in biological specimen transportation.”